Press Release (PressBurner) Nov 15, 2010 - Noida, Uttar Pradesh - Backed by cost effectiveness and skilled medical professionals, the Indian clinical trial market is expected to grow at CAGR of 29% during 2009-2013, says RNCOS.
According to our latest report entitled “Booming Clinical Trials Market in India”, India represents a fast growing market for clinical research and studies. The country has managed to position itself as one of the leading destinations for clinical trials over the past few years. The number of clinical trials has increased, which has provided a boost to the country’s reputation as a leading destination for these types of studies. The availability of world-class healthcare infrastructure, skilled medical professionals, and low cost for patients and volunteers are some of the main factors driving growth in this industry. The market is expected to perform well in future also and will reach US$ 768 Million by 2013, registering a CAGR of 29% since 2009.
The report has covered all the segments that play a significant role in Indian clinical trial market. The clinical research professionals play a key role in the attractiveness of sector as India has a large pool of medical practitioners with good skills and knowledge. Although the number of investigators and professionals remain less compared to those in developed world, the cost mechanism and skill offered by Indian healthcare persons are much effective.
The report “Booming Clinical Trials Market in India” is a complete picture of clinical trial market in India covering almost all key aspects relative to the market. It has covered sections like ‘cost analysis’ and ‘regulatory environment’ that elaborate relative cost structure and role of authorities in Indian clinical trial market respectively. The cost analysis section also represents a comparative analysis with respect to other developed countries. These two sections form the effectiveness of the report as cost and government support are the most important aspects for carrying out clinical trials.
Our report is an outcome of an in-depth research and prudent analysis of the Indian clinical trial market. It presents the current trends and future outlook of sector in a coherent manner. The forecasting section analyses the industry till 2013 making use of effective methods and techniques. The key activities and description of key players have also been analyzed along with important sections like ‘market trends’ and ‘patients pool availability’. Overall, the report is expected to facilitate the decision making process of clients and investors.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM564.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.
###